Maribavir is an effective and well-tolerated option for cytomegalovirus infection and disease among hematopoietic cell transplant recipients.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/real-world-data-support-maribavir-cmv-infection-after-2026a1000fmh?src=rss
Author :
Publish date : 2026-05-14 12:20:00
Copyright for syndicated content belongs to the linked Source.